Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma.

Leukemia - 1 Sept 2000

Chaperot L, Chokri M, Jacob M C, Drillat P, Garban F, Egelhofer H, Molens J P, Sotto J J, Bensa J C, Plumas J

Abstract excerpt

The recent clinical trial in lymphoma using tumor antigen-loaded DCs (Hsu et al, Nature Med 1996; 2: 52) demonstrates the efficiency of the use of professional antigen presenting cells (APCs) for taking up, processing and presenting tumor protein in a vaccine strategy in cancer. However, the prod...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to Antigen-Presenting Cells
Share to Dendritic Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukocytes, Mononuclear

Share to Lymphocyte Activation

Share to Lymphoma, Non-Hodgkin

Share to Phagocytosis

Share to Receptors, Fc

Source

Identifiers

PMID: 10995015
DOI: 10.1038/sj.leu.2401888

Genes

MAK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-10995015-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma.PMID 10995015Read ↗

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors.Semantic proximity Read ↗

A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapySemantic proximity Read ↗

Dendritic Cells in the Context of Human Tumors: Biology and Experimental ToolsSemantic proximity Read ↗

Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.Semantic proximity Read ↗

Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells.Semantic proximity Read ↗

In Vitro Methods to Evaluate Macrophage Polarization and Function in Cancer.Semantic proximity Read ↗

CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype.Semantic proximity Read ↗

Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro.Semantic proximity Read ↗

Induction of human tumor-loaded dendritic cells.Semantic proximity Read ↗

Phenotypical and functional characterization of clinical-grade dendritic cells.Semantic proximity Read ↗

Efficient generation of dendritic cells from alveolar and pleural macrophages as well as blood monocytes in patients with lung cancer.Semantic proximity Read ↗

Phenotypical and functional characterization of clinical grade dendritic cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.